A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.

Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts.

External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma.

Monoclonal antibody A7 tumor localization enhancement by its F(ab')2 fragments to colon carcinoma xenografts in nude mice.

Radioimmunoscintigraphy of human pancreatic carcinoma xenografts in nude mice with 131I-labeled monoclonal antibody.

Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragments.

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus.

Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma.

Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.

The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts.

Tumour size dependence of relative efficacy of radioimmunotherapy and external beam irradiation in tumour treatment.

CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice.

Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.

A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue.

Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.

Radioimaging of human glioma xenografts with 123I labeled monoclonal antibody G-22 against glioma-associated antigen.

Improving external beam radiotherapy by combination with internal irradiation.

External Beam Radiation in Differentiated Thyroid Carcinoma.

External-beam radiation for carcinoma of the prostate.

$Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma.$
Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma.

Video surface image guidance for external beam partial breast irradiation.

Suggest Documents

Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts.

External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma.

Monoclonal antibody A7 tumor localization enhancement by its F(ab')2 fragments to colon carcinoma xenografts in nude mice.

Radioimmunoscintigraphy of human pancreatic carcinoma xenografts in nude mice with 131I-labeled monoclonal antibody.

Quantitation of metastatic tumor burden from human colon tumor xenografts using radiolabelled monoclonal antibody 17-A fragments.

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus.

Comparison of external beam radiation and brachytherapy to external beam radiation alone for unresectable extrahepatic cholangiocarcinoma.

Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.

The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts.

Tumour size dependence of relative efficacy of radioimmunotherapy and external beam irradiation in tumour treatment.

CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice.

Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.

A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.

Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.

Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue.

Characterization of a neutralizing monoclonal antibody to the external glycoprotein of HIV-1.

Radioimaging of human glioma xenografts with 123I labeled monoclonal antibody G-22 against glioma-associated antigen.

Improving external beam radiotherapy by combination with internal irradiation.

External Beam Radiation in Differentiated Thyroid Carcinoma.

External-beam radiation for carcinoma of the prostate.

Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma.

Video surface image guidance for external beam partial breast irradiation.

A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts.

Recommend Documents

Follow Us